Accuray Financial Statements
Accuray Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | June |
This data is provided as per license from EDGAR Online
Accuray Income Statement
| 2007 | 2006 | 2005 | |
|---|---|---|---|
| Revenue ($ mil.) | 140.4 | 52.9 | 22.4 |
| Gross Profit ($ mil.) | 80.0 | 25.4 | 11.3 |
| Operating Income ($ mil.) | (8.5) | (33.5) | (24.9) |
| Total Net Income ($ mil.) | (5.6) | (33.7) | (25.2) |
| Diluted EPS (Net Income) | (0.18) | (2.11) | (1.76) |
Accuray Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 1.98 | 2.11 | 1.53 |
| Price/Earnings Ratio | 41.22 | 20.61 | 15.12 |
| Price/Book Ratio | 3.18 | 2.10 | 1.46 |
| Price/Cash Flow Ratio | -- | 15.31 | 9.52 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Accuray Financial Ratios
Accuray Competitive Intelligence
| Integra LifeSciences | Siemens Medical | Varian Medical Systems | |
|---|---|---|---|
| Annual Sales ($ mil.) | 550.5 | 7,478.2 | 1,776.6 |
| Employees | -- | 31,000 | 4,500 |
| Market Cap ($ mil.) | 1,212.2 | -- | 6,272.8 |
Competitive Landscape
